Show Notes
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down two GLP-1 studies that challenge a major media myth: GLP-1 medications don’t drive weight loss just because people eat less. Instead, drugs like tirzepatide and semaglutide create direct metabolic shifts—including increased fat oxidation and improved fuel partitioning—regardless of appetite. The team also explores mechanical eating, the psychological impact of “diet food,” and Andrea’s 13-year metabolic recovery journey.
Key Questions Answered If both groups are dieting, why does the tirzepatide group lose more weight? What is metabolic adaptation, and why does dieting slow metabolism so sharply? How do GLP-1s directly increase fat oxidation? What is mechanical eating, and why do GLP-1 users need it? Why does ad-lib eating produce different metabolic responses than calorie restriction? Can mindset alone change hunger hormones? (Yes—the milkshake study.) Why do diet foods and diet sodas fail to improve metabolic health? Why is response to GLP-1s so different from person to person?
Key Takeaways GLP-1s are metabolic drugs—not appetite suppressants. Their power comes from hormonal effects on fat burning, not reduced food intake. Calorie restriction still slows metabolism. Even on GLP-1s, dieting triggers significant metabolic slowdown. Ad-lib eating outperforms dieting in the research. Semaglutide users who ate freely did not show the extra metabolic slowdown seen in dieters. Mechanical eating is the most durable long-term approach. Regular meals and snacks protect lean mass and prevent famine signaling. Mindset shapes hormones. Believing a food is “diet” vs. “indulgent” alters ghrelin and satisfaction. Track body composition—not just the scale. DEXA scans show whether you’re losing fat, muscle, or bone.
Dr. Cooper’s Actionable Tips Don’t diet on GLP-1s. Focus on fueling, not restriction. Use mechanical eating: predictable meals and snacks, no long gaps. Prioritize satisfaction: diet foods often backfire hormonally. Follow your real-world data: long-term changes matter more than short-term scale shifts. Ask about body composition testing if possible.
Notable Quote: “What that study proved is that doing the calorie restriction is causing the metabolic slowing… and that’s why it’s so confusing to me that we keep advising people to restrict calories when they’re trying to improve their metabolic function.” —Dr. Emily Cooper
Links & Resources Podcast Home: https://fatsciencepodcast.com/ Episode References: https://fatsciencepodcast.com/wp-content/uploads/2025/06/Scientific-References-Fat-Science-Episodes.pdf Cooper Center: https://coopermetabolic.com/podcast/ Resources from Dr. Cooper: https://coopermetabolic.com/resources/ Submit a Question: [email protected] Dr. Cooper Email: [email protected]
Fat Science: No diets, no agendas—just science that makes you feel better. This podcast is for informational only, and is not intended to be medical advice.
More from Fat Science
Wondering why weight stalls on treatment? Dr. Emily Cooper explains how the brain defends set points and why eating less stops progress. Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener letters from around the world. The conversation addresses why athletic men with a BMI of 27 can still show high visceral fat on a DEXA scan, how medications defend metabolic set points, and why intentional undereating triggers starvation responses. The team also examines global access to metabolic treatments, dual incretin agonists versus single agonists, artificial sweeteners, and how to interpret two-hour insulin and glucose tolerance curves. Key Takeaways Rapid weight reduction without adequate nutrition can cause lean mass loss and trigger metabolic defense mechanisms. Dual incretin therapies stimulate GIP receptors far more than GLP-1 receptors compared to natural human hormones, creating different patient responses. Intentional calorie restriction reduces natural incretin production and can impair metabolic signaling, making mechanical fueling essential. Fasting insulin suppression combined with pre-diabetes indicators can reflect the brain pulling glucose during periods of low carbohydrate intake. Resources Mentioned Diabesity Foundations Course Cooper Center for Metabolism Diabesity Institute Connect with Us Podcast Home:fatsciencepodcast.com Cooper Center for Metabolism:coopermetabolic.com Diabesity Institute: diabesityinstitute.org Resources from Dr. Cooper:coopermetabolic.com/resources Join Our Community:patreon.com/cw/FatSciencePodcast Submit Your Question: [email protected] or [email protected] Fat Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care. This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations. Produced by: Podcast Impact Studio https://podcastimpactstudio.com
What do new drug reports really mean for your treatment? Explore groundbreaking updates on potential diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly. Dr. Emily Cooper dives into top-line results, explaining what these findings mean for those struggling with metabolic issues. KEY TAKEAWAYS Understanding the difference between efficacy estimand and treatment policy estimand.
Can metabolic dysfunction be the cause of anxiety?
What's the back-to-school metabolism shift all about?